ardiology science lunch erlin - charite

Post on 16-Nov-2021

5 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

Cardiology Science Lunch Berlina weekly exchange of insights and ideas in cardiovascular medicine

Campus Virchow Klinik

Wednesday, 24.05.2017

12:00 – 13:00h

Bibliothek at DHZBAugustenburger Platz 1, Berlin

x Bibliothek

The following CSLB is on 31.05.2017

Cardiology Science Lunch Berlin

is sponsored by

www.sciencelunch.de

Prof. Dr. med. Veselin MitrovicKerckhoff-Klinik Forschungsgesellschaft, Bad Nauheim

New Drugs and Perspectives in Treating Acute Heart Failure

Therapies for managing ADHF are far from ideal: Hospitalization rates anddisease mortality continue to increase, whereas current pharmacotherapyhas its limitations.As of today, no randomized trial has demonstrated a beneficial effect of anydrug on ADHF prognosis. Thus, there is still a urgent need for bettertherapies. Several drug classes have been developed to correct or mitigatedisordered pathways and, thereby, preserve and protect myocytes. Such arenatriuretic peptides, modulators of soluble and particulate guanylatecyclase, the vasoactive peptide serelaxin, HNO prodrugs, etc.Prof. Mitrovic will discuss the role of vasoactive drugs in the management ofADHF.

The Cardiology Science Lunch Teamfrom the Department of Cardiology, Charité Universitätsmedizin, Campus Virchow-Klinikum, Berlinand the Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin

Prof. Dr. med. Frank R. Heinzel, Ph.D.Dr. med. Tobias TrippelPD. Dr. Florian Blaschke

Dr. Paulina Wakuła, Ph.D.Christina Gaulhofer, BSc. MSc.Prof. Dr. med. Philipp Stawowy

Univ. Prof. Dr. med. Burkert Pieske

top related